Table of Contents Table of Contents
Previous Page  170-171 / 671 Next Page
Information
Show Menu
Previous Page 170-171 / 671 Next Page
Page Background

New agents……..

•

Trastuzumab (anti-HER-2)

•

Panitumumab (anti-EGFR)

•

Gefitinib (EGFR-inhibitor)

•

Erlotinib (EGFR-inhibitor)

•

PARB inhibitors

•

PD-1 and PD-L1 inhibitors

1 … 160-161 162-163 164-165 166-167 168-169 170-171 172-173 174-175 176-177 178-179 180-181 182-183 … 671  FlippingBook